Interactions between the microbiota and distal gut are important for the maintenance of a healthy intestinal barrier; dysbiosis of intestinal microbial communities has emerged as a likely contributor to diseases that arise at the level of the mucosa. Intraepithelial lymphocytes (IELs) are positioned within the epithelial barrier, and in the small intestine they function to maintain epithelial homeostasis. We hypothesized that colon IELs promote epithelial barrier function through the expression of cytokines in response to interactions with commensal bacteria. Profiling of bacterial 16S ribosomal RNA revealed that candidate bacteria in the order Bacteroidales are sufficient to promote IEL presence in the colon that in turn produce interleukin-6 (IL-6) in a MyD88 (myeloid differentiation primary response 88)-dependent manner. IEL-derived IL-6 is functionally important in the maintenance of the epithelial barrier as IL-6 À / À mice were noted to have increased paracellular permeability, decreased claudin-1 expression, and a thinner mucus gel layer, all of which were reversed by transfer of IL-6 þ / þ IELs, leading to protection of mice in response to Citrobacter rodentium infection. Therefore, we conclude that microbiota provide a homeostatic role for epithelial barrier function through regulation of IEL-derived IL-6.
INTRODUCTION
The mammalian gastrointestinal tract supports the existence of trillions of bacteria. A critical mutualism exists within the intestinal mucosa, where microbes can not only promote health but also promote multiple mucosal diseases. 1 Tissue barrier function is a critical determinant of health, and epithelial cell homeostasis is crucial for maintenance of effective barrier function. Although epithelial homeostasis depends upon interactions with microbes, innate immune cells, and stroma, 2 the precise roles of these factors have yet to be elucidated.
Intraepithelial lymphocytes (IELs) are a unique population of antigen-experienced T cells anatomically associated with epithelial cells that function to protect the host from microbial invasion and maintain epithelial homeostasis. 3 Our understanding of IELs is derived from murine studies in the small intestine (SI) where a majority of IELs are TCRgd þ CD8aa þ .
One hallmark of SI IELs is the expression of CD103 (aE integrin) that allows them to home to the SI. CD103 interaction with E-cadherin on epithelial cells maintains the localization of SI IELs. 4 Microbial sensing through NOD2 (nucleotide-binding oligomerization domain-containing protein 2) and the MyD88 (myeloid differentiation primary response 88) pathway result in epithelial cell production of interleukin-15 (IL-15) that stimulates IEL proliferation and effector functions, 5, 6 including maintenance of barrier function through several mechanisms. For example, gdIELs of the SI stimulate epithelial cells to secrete the antimicrobial peptide RegIIIg; 7 and IEL secretion of transforming growth factor-b, interferon-g, and keratinocyte growth factor protects and repairs epithelial cells after injury. 3 However, many of these features and functions are unique to gdIELs of the SI, whereas this represents a minor subpopulation of IELs in the colon. Our understanding of how colon IELs contribute to barrier function is still unclear.
Previous work has demonstrated that TCRb þ CD4 À CD8 À IELs in the murine and human colon produce IL-6 early after mechanical and inflammatory injury to the epithelium. 8 IL-6 is known to signal through two mechanisms: cis-signaling in which soluble IL-6 binds its heterodimer receptor of IL-6Ra and gp130 on the cell surface; or trans-signaling in which soluble IL-6 and secreted IL-6Ra form a complex and then bind membrane-bound gp130. 9 Generally, IL-6Ra is found on lymphocytes and hepatocytes whereas the co-receptor gp130 is ubiquitously present; 9 the presence of IL-6R on epithelia and how IL-6 signals in these cells remains unknown.
Upon ligation of the IL-6Ra and gp130, one of two pathways is activated: the signal transducer and activator of transcription 3 (STAT3) or Src-homology tyrosine phosphatase (SHP2)/Ras/ extracellular signal-regulated kinase (ERK). Colonic epithelial cell homeostasis and wound healing appears to require the STAT3 pathway. 10 Some studies suggest that IL-6 signaling stimulates epithelial stem cell proliferation, 8 whereas others have suggested that IL-6 protects intestinal epithelial cells from apoptosis during dextran sodium sulfate-induced colitis and Citrobacter rodentium infection in mice. [11] [12] [13] Nevertheless, the source of, and stimulus for, IL-6 during intestinal epithelial homeostasis have not been established.
In the present studies, we hypothesized that colon IELs promote epithelial barrier function through the secretion of cytokines, particularly IL-6, stimulated by interactions with commensal microbes. Our results demonstrate that bacterial members in the order Bacteroidales aid in establishing IL-6producing IELs in the colon, and MyD88-dependent signals are required for IEL production of IL-6. Importantly, the loss of IL-6-producing IELs impairs the integrity of the epithelial barrier through reductions in both tight junction expression and mucus thickness that are important in the host's defense against C. rodentium colitis. These studies suggest a novel pathway of microbiota stimulation of cytokine production in intestinal epithelial barrier homeostasis.
RESULTS

Bacteria of the order Bacteroidales are sufficient to maintain the colon IEL population
Studies utilizing germ-free and antibiotic-treated mice have demonstrated that the presence of IELs in the SI is dependent on microbial colonization. 6, 14, 15 Microbial stimulation of NOD2 and the MyD88 pathway in the SI epithelium lead to epithelial IL-15 secretion and the recruitment of IELs. 5, 6 We verified that microbial depletion through administration of broad-spectrum antibiotics (1 mg ml À 1 each of ampicillin, metronidazole, and neomycin, and 0.5 mg ml À 1 vancomycin in drinking water) for 1 week significantly reduced IELs in the colon as assessed by immunofluorescence staining for epithelial CD3 þ cells (Figure 1a ,b) and flow cytometry (Supplementary Figure S1 online); this loss of IELs was reversible as recolonization by cohousing with control littermates resulted in an increase in IEL numbers. Furthermore, we confirmed the requirement for microbial stimulation of Toll-like receptors and/or IL-1 family pathways in the colon as MyD88 À / À mice were found to have significantly reduced colon IELs (Figure 1c ). In an attempt to identify bacteria necessary to maintain the colon IEL population, mice were treated with individual antibiotics or in combination for 1 week followed by analysis of colon IELs by flow cytometry. All antibiotic treatments decreased the total number of colon IELs (Figure 1d ). As expected, treatment of mice with individual antibiotic classes had differing impacts on the microbial populations (Supplementary Figure S2a ). It is notable that all antibiotics had a significant influence on reducing members of the class Bacteroidia. Based on these initial findings, we performed 16S ribosomal RNA sequencing of the fecal microbiome from five untreated and five combination antibiotic-treated mice. When comparing relative abundance of operational taxonomic units (OTUs) at the order level, the Wilcoxon rank test demonstrated that Bacteroidales were most significantly reduced in antibiotictreated mice (Figure 1e and Supplementary Figure S2b ), and within Bacteroidales, a Wilcoxon rank test identified the genus Alistipes were the most significantly reduced by antibiotic treatment (Supplementary Figure S2c ). We measured by quantitative PCR (qPCR) the relative abundance of this genus in our single-antibiotic treated mice compared with untreated mice. Although Alistipes bacterial DNA was readily detected by qPCR of its 16S ribosomal RNA in untreated mice, it did not amplify in the samples from antibiotic-treated mice (Supplementary Figure S2d) , confirming that Alistipes were depleted by each antibiotic treatment. Recolonized mice, which have an increased IEL population compared with antibiotictreated mice (Figure 1a,b and Supplementary Figure S1 ), demonstrate increased Alistipes compared with the antibiotictreated mice (Supplementary Figure S2d) . These data suggest that Bacteroidales, including Alistipes, are important for the presence of IELs in the colon.
To test our hypothesis that Bacteroidales are sufficient for the presence of colon IELs, we monocolonized germ-free mice with Alistipes onderdonkii as well as closely related and well-characterized Bacteroides fragilis and Bacteroides thetaiotamicron. 16, 17 We confirmed the B. thetaiotamicron and B. fragilis were also depleted in abundance in our antibiotictreated mice ( Supplementary Figure 2e ). As controls, germfree mice were gavaged with an unrelated species Escherichia coli or phosphate-buffered saline (PBS). Colonization of mice with each species was not significantly different as confirmed by culture of cecal contents (Supplementary Figure S3 ). Monocolonization with A. onderdonkii, B. fragilis, and B. thetaiotamicron significantly increased the number of IELs in the colon compared with E. coli and PBS-gavaged mice (Figure 1f ), confirming that at least some species within the order Bacteroidales, but not E. coli, are sufficient to maintain IELs in the colonic epithelium.
IL-6 secretion by IELs requires bacterial signals
Colon IELs previously have been shown to produce IL-6, 8 and this we verified by intracellular cytokine staining and flow cytometry analysis of IELs from untreated C57Bl/6 mice (Supplementary Figure S4 ). However, the stimulus for IL-6 production is unclear. Therefore, we evaluated the production of IL-6 in response to resident bacteria. Again, mice were treated with broad-spectrum antibiotics for 1 week ± recolonization by cohousing with untreated littermates for 1 week. IELs were magnetically sorted and mitogen stimulated ex vivo. Purity of our EDTA liberation and magnetic sorting of IELs was confirmed by flow cytometry (Supplementary Figure S5 ). As shown in Figure 2a , IL-6 tracked with the presence of microbial-derived signals under conditions of antibiotic treatment and recolonization. IL-6 was not produced by potential contaminating lamina propria T cells because CD3 þ cells isolated from collagenase digests of colon tissue following EDTA liberation of IELs did not produce detectable IL-6 after mitogen stimulation (Figure 2a ). Toll-like receptor and/or IL-1 family signals through MyD88 were also required for IEL secretion of IL-6, as IELs from MyD88 À / À mice did not secrete detectable levels of IL-6 ( Figure 2a ). As antibiotic treatment resulted in decreased numbers of IELs in the SI 6 and colon (Figure 1 and Supplementary Figure S1b ), we queried whether the production of IL-6 may be because of the reduced number of IELs. When normalized to the average number of CD4 À CD8 À IELs, secretion of IL-6 continued to track with the presence of the microbiota (Supplementary Figure S6b) . Because A. onderdonkii, B. fragilis, and B. thetaiotamicron maintained the IEL population in gnotobiotic mice, we tested whether these strains could modulate IELs to produce IL-6 relative to PBS and E. coli. Colonization with A. onderdonkii, B. fragilis, or B. thetaiotamicron led to variable IL-6 production by IELs that was substantially higher than that produced by IELs isolated from E. coli or PBS-gavaged germ-free mice (Figure 2b and Supplementary Figure S6c ).
IL-6 promotes barrier function and induces epithelial claudin-1 and mucin-2 expression
Although epithelial damage is limited by IL-6 signaling, 8, [11] [12] [13] surprisingly little is known about IL-6 and epithelial barrier function. To understand how IL-6 affects the epithelial barrier, we utilized T84 cells, a well-characterized human colon epithelial cell line widely used to study barrier regulation. 18 IL-6Ra protein was observed in lysates from both T84 cells and murine primary epithelial cells, indicating that these cells could respond to IL-6 cis-signaling ( Figure 3a) . Addition of IL-6 strongly induced STAT3 phosphorylation and SOCS3 expression in T84 cells, as determined by western blot and qPCR, respectively, verifying that IL-6 is able to signal through epithelial-expressed surface IL-6 receptors (Figure 3b ,c). To define functional responses to IL-6, T84 cells were plated on membrane-permeable supports in either the absence or presence of IL-6 and monitored during the formation of barrier as measured by transepithelial resistance and permeability to fluorescein isothiocyanate (FITC)-dextran. As shown in Figure 3d ,e, by day 4 of cell culture, IL-6 induced a prominent increase in the rate of barrier formation by transepithelial resistance (Po0.01) and concomitant decrease in paracellular permeability (Po0.0001), revealing that activation of IL-6 receptor on intestinal epithelia promotes barrier formation.
Because paracellular permeability of FITC-dextran was affected by IL-6, we assessed the effect of IL-6 on epithelial tight junction proteins. T84 cells were treated with IL-6, and expression of a panel of tight junction proteins was profiled by qPCR using previously described methods. 19 This approach identified a significant increase in the expression of CLDN1. A so-called ''tight claudin,'' CLDN1 plays an integral role in determining barrier function in IECs. 20 As shown in Figure 3f , exposure of epithelia to IL-6 induced CLDN1 mRNA and was confirmed at the protein level ( Figure 3g ). Such observations strongly implicate a role for IEL-derived IL-6 in the induction of epithelial barrier integrity via claudin-1.
Another important component of the epithelial barrier is the mucus layer. Adherent to the epithelium is a tight matrix of mucin-2 glycoprotein (MUC2) followed by a loosely associated matrix at the luminal edge. The inner layer is sterile whereas commensal bacteria colonize the loose outer layer. 21 Because studies have demonstrated higher epithelial susceptibility to C. rodentium in IL-6 À / À mice, 12 and STAT3 can induce MUC2 gene expression, 22, 23 we reasoned that IL-6 may also have an effect on the mucus layer during homeostasis. T84 cells treated with IL-6 were noted to have increased MUC2 expression ( Figure 3h ), suggesting that IL-6 may also influence mucus production as part of its role in the maintenance of barrier function.
IL-6 maintains the epithelial barrier in vivo
Next, we aimed to verify that IEL-produced IL-6 was necessary to maintain the epithelial barrier through the same mechanisms in vivo. First, we assessed the epithelial permeability of FITC-dextran in IL-6 À / À mice compared with controls and antibiotic-treated mice. Compared with untreated mice, mice administered antibiotics as well as IL-6 À / À mice showed a greater than threefold increase in serum levels of FITC-dextran (P ¼ 0.001). This permeability defect was reversible, as recolonization of antibiotic-treated mice led to permeability normalization, indifferent from untreated mice ( Figure 4a ). Similar to T84-cultured cells treated with IL-6, we found claudin-1 protein staining by immunohistochemistry significantly increased in the colonic epithelium of IL-6 þ / þ mice compared with IL-6 À / À mice (Figure 4b ), suggesting that IL-6-stimulated claudin-1 expression may be one mechanism that promotes barrier integrity. In addition, we confirmed a mucus layer defect in the colons of IL-6 À / À mice relative to wild-type mice by immunofluorescence. Mice deficient for IL-6 demonstrated a significantly reduced mucus layer thickness (Figure 4c,d) . Thus, we conclude that IL-6 is critical in maintaining the intestinal barrier via multiple mechanisms, including stimulation of tight junction formation and mucus production.
IEL-derived IL-6 decreases epithelial permeability and protects from C. rodentium colitis
To demonstrate the IEL source of IL-6 was necessary, we isolated colon IELs from donor IL-6 þ / þ or IL-6 À / À mice and transferred them into IL-6 þ / þ or IL-6 À / À recipients. After 1 week, barrier permeability was assessed by the presence of serum FITC-dextran after oral gavage. Unlike transferring IL-6 À / À IELs into IL-6 À / À mice, transfer of IL-6 þ / þ IELs into recipient IL-6 À / À mice resulted in restoration of barrier permeability similar to transfer of IL-6 þ / þ IELs into IL-6 þ / þ mice (Figure 5a) . In a separate experiment, we confirmed that IELs will track to the colon when transferred in this manner using IELs isolated from CD45.1 congenic C57Bl/6 that were injected into wild-type, CD45.2 recipients (Supplementary Figure S7 ). These data demonstrate that IEL-derived IL-6 is sufficient to maintain an effective epithelial barrier.
Previous studies have shown IL-6 À / À mice have decreased survival and worse histopathology when infected with C. rodentium. 12 Thus, to demonstrate that IEL-produced IL-6 would restore barrier protection during disease, we orally infected mice with this pathogen following transfer of donor IL-6 þ / þ or IL-6 À / À IELs into IL-6 þ / þ or IL-6 À / À recipients. IL-6 À / À mice that received IL-6 À / À IELs had significantly more weight loss and increased intestinal histopathology after 12 days of infection compared with transfer of IL-6 þ / þ IELs into recipient IL-6 À / À mice and IL-6 þ / þ IELs into IL-6 þ / þ mice (Figure 5b-e ). Therefore, we conclude that IL-6 expression by IELs is sufficient to restore protection against C. rodentium infection. IL-6 produced by IELs restores claudin-1 expression and mucus thickness in IL-6 À / À mice during C. rodentium infection Analyses of tissue sections from mice treated with IEL transfers followed by C. rodentium infection for 12 days demonstrated that transfer of IL-6 þ / þ IELs into IL-6 À / À mice repaired the defective epithelial barrier of IL-6 À / À mice. Transfer of IL-6 þ / þ IELs into IL-6 À / À mice resulted in significantly reduced bacterial translocation and increased mucus thickness compared with IL-6 À / À IELs into IL-6 À / À mice (Figure 6a-c) . Claudin-1 expression increased with IL-6 þ / þ IELs given to IL-6 À / À mice similar to IL-6 þ / þ IELs to IL-6 þ / þ but nearly absent in IL-6 À / À IELs to IL-6 À / À mice (Figure 6d,e ). Together, these results indicate that IL-6 produced by IELs can improve some functions of the epithelial barrier that are impaired in IL-6 À / À mice.
DISCUSSION
IL-6 is an important cytokine for intestinal epithelial repair after injury. However, details regarding its role during intestinal homeostasis, stimulus for secretion, cellular source, and mechanistic function were unknown. In this study, we hypothesized that IEL-derived IL-6 was critical for intestinal homeostasis. Our results demonstrate that a subset of Bacteroidales is sufficient to maintain IELs in the colon where they produce IL-6 dependent upon MyD88 signals. Moreover, IEL-derived IL-6 is functional and promotes barrier function via claudin-1 protein expression and increased mucus thickness that are protective against C. rodentium infection.
Despite our findings, several questions remain regarding how IELs are recruited to the colon and stimulated to produce IL-6. Multiple prior studies have shown microbiota to be regulators of the IEL population through NOD2 and MyD88 signaling in epithelial cells. 6, 7 Our studies are in agreement and further demonstrate that specific microorganisms, namely members of the bacterial order Bacteroidales, are sufficient to maintain the colon IEL population, although the mechanism by which the species within Bacteroidales maintain colon IELs is not immediately clear. In the SI, MyD88 signaling in epithelial cells results in IL-15 production that retains a portion of the IEL population there. 5 However, these data do not explain why certain bacterial strains within Bacteroidales were able to maintain the IEL population in our studies. More recent studies have identified cell surface short-chain fatty acid receptors on populations of mucosal T cells 24 and past work has suggested that one of the short-chain fatty acids, butyrate, may provide a proliferative or homing signal for some CD8 þ populations of IEL in the rat colon. 25 Although our studies focus upon the role of IEL-derived IL-6, there are additional sources of IL-6 within the intestinal mucosa including epithelial cells, monocytes, and other T cells. Yet, transfer of IL-6 þ / þ IELs into IL-6-deficient mice was sufficient to reverse the intestinal permeability defect apparent in IL-6 À / À mice, indicating that IELs are a dominant source of IL-6 for mucosal barrier function. Although the purity of our transferred cells is robust, reducing the possibility of inadvertently transferring other cellular sources of IL-6, some IELs trafficked to the SI and a small percentage to the spleen. It remains unclear how this pattern of trafficking might influence intestinal permeability. Nonetheless, given that most cells return to the intestine suggests that the IEL activities remain mostly local.
Our data reveal an important function for IEL-derived IL-6 in maintaining epithelial homeostasis and protection during barrier impairment. One mechanism is via IL-6 signaling through STAT3 to induce expression of claudin-1.
Interestingly, per our review of the CLDN1 promoter sequence, there are four predicted STAT3-binding sites, supporting our findings. It is notable that recent work implicates IL-6 as a cytokine in the disruption of epithelial barrier function in vitro through increased expression of the ''leaky'' tight junction claudin-2. 26, 27 These studies, though, demonstrated the pathway to occur through IL-6 activation of the Akt and ERK pathways that we did not find in our studies. Such a discrepancy between cytokines functioning as both barrier disruptors and barrier promoters has been described before. For example, Figure 6 Transfer of IL-6 þ intraepithelial lymphocytes (IELs) into IL-6 À / À mice restores the mucus layer and claudin-1 expression. (a) Fluorescent in situ hybridization (FISH) was performed on tissues from Figure 5 interferon-g has long been known to disrupt epithelial barrier function, 28 whereas more recent studies have shown an important role for interferon-g in the restitution of epithelial barrier through a mechanism involving induction of IL-10 receptors on intestinal epithelial cells. 29 Notably, in vivo studies have supported a protective role for IL-6 by promoting intestinal epithelial proliferation and wound healing. 8 Placed in context, such results indicate a dynamic process wherein IL-6 produced by differing cell types may modulate barrier function differently during inflammation, tissue repair, and homeostasis.
Goblet cell function including mucus production (MUC2 expression) and secretion is known to be modulated by cytokines, particularly T helper type 2 cell response-driven cytokines (STAT6 signaling) and IL-22 and IL-10 (via STAT3). 22, 23, 30 Because IL-6 also acts via the STAT3 pathway in our studies, we reasoned that it would also modulate MUC2 expression. We found increased MUC2 expression in vitro in T84 cells with IL-6 treatment, similar to others' observations in LS180 colon adenocarcinoma cell line, 31 and increased mucus thickness in the presence of IEL-derived IL-6 in vivo. However, in vivo, our data do not address whether IL-6 may be acting directly on MUC2 expression in goblet cells or indirectly through other cells and mediators that stimulate goblet cell function. In addition, our evaluation of the mucus layer in vivo was limited to wheat germ agglutinin staining and thickness of the layer. It does not depict the quality of or glycan content in the layer.
Although we interpret our data as IL-6 þ IELs stimulate enterocyte claudin-1 and mucin-2 to protect mice during C. rodentium infection, the barrier integrity may only be an indirect consequence of reduced inflammation. IL-6 produced by IELs may lead to protection of epithelial cell apoptosis or stimulation of epithelial proliferation as previously suggested by others, 8, [11] [12] [13] resulting in a more intact barrier with increased claudin-1 and mucin-2 presence. In support of this, others have shown the tight junction claudin-3 to be disrupted only when C. rodentium attaches to enterocytes, 32 suggesting that tight junctions are influenced by pathogen attachment and not host signals. Thus, an alternate interpretation of our data would be that disease severity is decreased in the presence of IL-6 þ IELs causing reduced C. rodentium access to the epithelium and less disruption of claudin-1. Nevertheless, this interpretation still supports the conclusion that IL-6 þ IELs are protective.
Although our data indicate that IEL-produced IL-6 acts directly on epithelial cells to promote barrier integrity, it remains unclear whether the protective influences of IL-6 during C. rodentium infection are directly mediated by our proposed mechanism. Numerous cells, cytokines, and signaling pathways are involved in the murine response to C. rodentium. 33 Where IL-6 intersects with these pathways remains unknown, although one study using IL-6 À / À mice suggested its role was upstream of IL-17 and IL-22. 34 In that report, IL-17A and IL-17F signaling through IL-17RC were dispensable but IL-22 was required for survival during infection. However, using alternate approaches for genetic deletion of IL-17 homologs and their receptors, others have found this pathway to be important for protection against C. rodentium, with IL-17C acting in synergy with IL-22. 35, 36 Thus, it is reasonable to query whether IL-6 þ IELs transferred in our studies function to stimulate IL-17 and IL-22 pathways that protect against C. rodentium infection in addition to our proposed mechanism.
Taken together, this work highlights the importance of a finely balanced mutualism between the host and microbiota within the mucosa. A clearer understanding of the molecular basis of such crosstalk between gut-derived signals and the IELs within the mucosa are likely to shed important light on potential therapeutic targets for mucosal disease.
METHODS
Animals. C57Bl/6, CD45.1 congenic (B6.SJL-Ptprca Pepcb/BoyJ), IL-6 À / À and MyD88 À / À breeding pairs on the C57Bl/6 background were obtained from Jackson Laboratories (Bar Harbor, ME). Strains were bred and maintained in the University of Colorado Anschutz Medical Campus animal facility in standard specific pathogen-free conditions as well as in germ-free isolators. All use was approved by the institutional animal care and use committee. Both male and female mice were used at the age of 8-12 weeks. To control for variations in microbiota, littermates and cohousing were utilized. Treatment of mice with antibiotics was done by placing 0.5 mg ml À 1 vancomycin and 1 mg ml À 1 each of ampicillin, metronidazole, and neomycin (Sigma, St Louis, MO) as a combination or individually into drinking water supplemented with 20 mg ml À 1 grape-flavored sugarsweetened Kool-Aid (Kraft Foods, Deerfield, IL). Untreated mice were provided drinking water with Kool-Aid alone. After 1 week, mice were either euthanized for studies or recolonized by cohousing antibiotic-treated mice with unmanipulated littermates for 1 week.
For monocolonization experiments, germ-free C57Bl/6 mice (obtained from the National Gnotobiotic Rodent Resource Center, University of North Carolina, Chapel Hill, NC, and bred and maintained locally in sterile vinyl isolators) were gavaged with 200 ml liquid bacterial culture of the following obtained from American Type Culture Collection (ATCC, Manassas, VA): Alistipes onderdonkii WAL 8169, Bacteroides thetaiotamicron VPI-5482, Bacteroides fragilis NCTC 9343, and Escherichia coli K12. At the time of animal euthanasia, cecal contents were serially diluted in PBS and cultured on 10% sheep red blood cell agar plates to determine bacteria colonization levels.
Permeability of the colonic epithelial barrier was evaluated by absorption of FITC-dextran. Mice were given 0.6 mg kg À 1 body weight of 4 kDa FITC-dextran (Sigma) by oral gavage, and sera were collected after 4 h. The amount of fluorescence was measured with a fluorimeter (Promega, Madison, WI) at 485/530 nm. A standard curve was generated to calculate the amount of dextran that was present in the sera.
C. rodentium infection was performed utilizing the protocol by Bhinder et al. 37 Briefly, 200 ml of a fresh overnight culture of C. rodentium (ATCC, strain DBS100) was orally gavaged into each mouse to induce disease. Body weight was monitored daily throughout the study that was terminated 12 days after infection at which time mice were euthanized and tissues collected for analyses.
Isolation, analysis, and transfer of IELs and primary epithelial cells.
After euthanasia of mice, the colon with cecum was removed, flushed with PBS without magnesium or calcium, and placed in PBS with 1 mM EDTA. The tissues were vortex-agitated for 10 min at room temperature, placed through 70 mm nylon mesh, and pelleted by centrifugation. Cells were resuspended in PBS with 5% fetal calf serum, counted, and used for further analyses.
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For flow cytometry, 0.5 ng ml À 1 fluorescently labeled antibodies (eBioscience, San Diego, CA; BioLegend, San Diego, CA; and Tonbo Biosciences, San Diego, CA) were added to the cells: CD3e (17A2), CD4 (GK1.5), CD8a (53-6.7), CD8b (H35-17.2), TCRb (H57-597), TCRgd (GL3), CD45 (30-F11), CD45.1 (A20), and Ghost Dye Violet 510 (Tonbo). Intracellular staining was performed using commercial intracellular staining fixation and permeabilization buffers (Tonbo) and anti-IL-6 (MP5-20F3) or Rat IgG1 isotype control (Tonbo). Cells were run on a LSR II flow cytometer (BD Biosciences, San Jose, CA). Data were analyzed using FlowJo software (V.10.0.8, Ashland, OR).
Purification of IELs was performed by magnetic separation using the EasySep Mouse T Cell Isolation Cocktail (Stem Cell Technologies, Vancouver, BC, Canada) and biotinylated anti-EpCAM (G8.8). Isolated cells were then resuspended in RPMI-1640 media with 10% fetal calf serum and divided into two wells of a 96-well cell culture plate. Then, 10 ng ml À 1 phorbol 12-myristate 13-acetate and 1 mg ml À 1 ionomycin were added to one well. Cells were incubated at 37 1C for 2 h with protein transport inhibitor cocktail (eBioscience; for intracellular cytokine staining) or for 5 h without a protein transport inhibitor (for ELISA). Cell culture supernatants were harvested for cytokine analysis by ELISA (Meso Scale Discovery, Rockville, MD).
For experiments in which IELs were transferred into recipient mice, magnetically sorted IELs from C57Bl/6 mice were labeled with CellVue Jade Cell Labeling Kit (eBioscience), or IELs from CD45.1 congenic mice were counted and suspended in PBS at a concentration of 1-2 Â 10 6 cells per ml. Then, 100 ml of cells were then injected intravenously via the tail vein into recipient mice.
Assessment of microbiota. DNA from feces was isolated using a commercial kit (UltraPure Fecal DNA, Mol Bio, Carlsbad, CA). The concentration of DNA was determined by spectrophotometry (Nanodrop, Thermo Fisher Scientific, Waltham, MA) and normalized to fecal pellet weight. qPCR for Bacteroidia class, Clostridiales order, Enterobacteriaceae family, Enterococcus family, Lactobacillaceae family, Alistipes genus, and Bacteroides thetaiotamicron-and Bacteroides fragilis-specific 16S DNA was performed and normalized to a universal bacterial 16S primer set. 38, 39 Supplementary Table 1 lists primer sequences used and their references.
For microbiome analysis, harvested DNA from fecal pellets was PCR amplified with broad-range bacterial primers targeting the 16S ribosomal RNA gene V1V2 region and pooled amplicons subjected to Illumina MiSeq sequencing, as previously described. [40] [41] [42] Assembled sequences were aligned and classified with SINA (1.3.0-r23838) 43 using the 418,497 bacterial sequences in Silva 115NR99 (ref. 44) as reference configured to yield the Silva taxonomy. OTUs were produced by clustering sequences with identical taxonomic assignments. Analyses of OTU relative abundance and biodiversity were conducted using Explicet software. 45 All samples had a Good's coverage index 499%, indicating excellent depth of sequencing coverage.
When analyzing the microbiome data to determine differences between C57Bl/6 untreated and antibiotic-treated mice (N ¼ 5 each group), the relative abundance of OTUs at the order level was compared using the Wilcoxon rank test to identify significant differences between groups. A P value of o0.05 was considered significant. Within the most significant order Bacteroidiales, the family-level OTUs were compared with the Wilcoxon rank test.
Histology, fluorescent in situ hybridization, and immunohistochemistry. Colon tissues were dissected from mice and placed whole and unflushed in methacarn (60% methanol, 30% chloroform, and 10% glacial acetic acid) fixative overnight. Tissues were then washed two times in 100% methanol for 30 min each and then two times in xylenes for 20 min each followed by embedding into paraffin. For histological examination 5 mm sections were cut, stained with hematoxylin and eosin, and coverslipped.
For fluorescent in situ hybridization FISH, 5 mm sections of methacarn-fixed, paraffin-embedded mouse colon were deparaffinized by heating at 72 1C for 30 min followed by passage through xylenes and then alcohols. Slides were crosslinked with ultraviolet subtype-C for 20 min in PBS and then air dried. A eubacterial fluorescent in situ hybridization probe (EUB-338; 5 0 -GCTGCCTCCCGTAGGAGT-3 0 ), 46 5 0 labeled with AlexaFluor568 (Molecular Probes, Thermo Fisher Scientific, Waltham, MA), was reconstituted with sterile water and diluted to a working concentration of 10 ng ml À 1 with hybridization buffer (20 mM Tris-HCl, 0.1% sodium dodecyl sulfate, 0.9 M NaCl, pH 7.2, 5% formamide). The sections were hybridized at 50 1C overnight. Slides were washed in wash buffer (hybridization buffer without SDS or formamide) at 50 1C for 30 min. Slides were then counterstained with AlexaFluor 488 wheat germ agglutinin (Molecular Probes) and 4',6-diamidino-2-phenylindole, mounted with ProLong antifade (Molecular Probes), and evaluated by fluorescent microscopy (AxioCam MR c5 attached to an AxioImager A1 microscope, Zeiss, Oberkochen, Germany).
Immunohistochemistry was performed on 5 mm sections of methacarn-fixed, paraffin-embedded mouse colon. Following deparaffinization and rehydration, tissue was treated with 3% H 2 O 2 in methanol for 15 min at room temperature and then washed with deionized water followed by PBS. Primary antibody claudin-1 (rabbit polyclonal, Invitrogen, Thermo Fisher Scientific, Waltham, MA) diluted 1:200 with 3% bovine serum albumin in PBS was applied to tissue overnight at 4 1C. Secondary antibody horseradish peroxidaseconjugated anti-rabbit (Bio-Rad, Hercules, CA) diluted 1:3,000 with 3% bovine serum albumin in PBS was applied for 1 h at room temperature. Following washing, slides were developed with DAB using a commercial kit (Vector Laboratories, Burlingame, CA), counterstained with hematoxylin, and coverslipped. Slides were evaluated with light microscopy.
Cell culture and western blot. T84 cells (ATCC, Manassas, VA) cultured in Dulbecco's modified Eagle's medium/F12 (Thermo Fisher Scientific) with 10% fetal bovine serum were grown to confluence in 24-well plates. Media were replaced with and without 50 ng ml À 1 recombinant human IL-6 (Tonbo Biosciences). After 24 h, cells were lysed in either Trizol for RNA extraction or Tris-lysis buffer containing protease inhibitors (Pierce, Thermo Fisher Scientific, Waltham, MA). Protein concentration was determined by BCA (Pierce). Protein was separated by electrophoresis on 10% SDS-polyacrylamide gels, transferred to polyvinylidene difluoride membranes, and probed with antibodies to actin (polyclonal, Abcam, Cambridge, MA), STAT3 (79D7, rabbit monoclonal antibody, Cell Signaling Technology, Danvers, MA), pSTAT3 (3E2, mouse monoclonal antibody, Cell Signaling Technology), IL-6Ra (polyclonal, Santa Cruz, Dallas, TX), and claudin-1 (rabbit polyclonal, Invitrogen).
T84 cells were then grown to confluence on 0.33 cm 2 , 0.4 mm permeable polyester inserts (Corning, Corning, NY) in the absence or presence of 50 ng ml À 1 IL-6. Transepithelial resistance was measured using the EVOM2 voltammeter (World Precision Instruments, Sarasota, FL) and expressed as Ohms Â cm 2 . Paracellular permeability was assayed using FITC-Flux assay: confluent T84 monolayers on 0.33 cm 2 , 0.4 mm permeable polyester inserts were washed and equilibrated in Hanks' balanced salt solution. Then, 1 mg ml À 1 FITC-dextran, 3 kDa (Sigma) was added to the apical compartment and samples were taken from the basolateral compartment every 30 min for 2 h. Fluorescence was determined using a Glomax Multi fluorescent plate reader (Promega) and represented as the change in fluorescence over time.
RNA isolation and qPCR. RNA from primary cells or T84 cells was extracted using Trizol. RNA concentration was determined by spectrophotometry (Nanodrop), and then converted to complementary DNA (cDNA) using iScript (Bio-Rad). qPCR of cDNA for actin, SOCS3, claudin-1, -2 and -4, and mucin-2 was performed. 19, 29 Supplementary Table 1 lists the primer sequences used. Reactions consisted of 1 ml cDNA, 0.6 mM each of forward and reverse primers, 1 Â SYBR Green PCR Master Mix (Applied Biosystems, Foster City, CA), and water for a total volume of 17 ml. Samples were denatured at 95 1C for 2 min, cycled 40 times through 95 1C for 20 s, 58 1C for 20 s, and 72 1C for 30 s, and then denaturation curves determined from 58 1C through 95 1C. All qPCR assays were conducted in a Applied Biosystems 7500 real time PCR system. Specificity of amplicon was verified by agarose gel electrophoresis.
SUPPLEMENTARY MATERIAL is linked to the online version of the paper at http://www.nature.com/mi
